Pfizer and BioNTech COVID-19 vaccine positive results in adolescents
Photo Cred: Mat Napo/Unsplash By Katherine Shagoury Pfizer and BioNTech’s two-dose novel coronavirus (COVID-19) vaccine showed 100 percent efficacy and robust antibody responses in adolescents ages 12 to 15 years...
Read MoreCOVID-19 vaccines 90 percent effective, CDC says
Photo Cred: Joshua Hoehne/Unsplash By Katherine Shagoury The Pfizer and BioNTech and Moderna novel coronavirus (COVID-19) vaccinations are 90 percent effective at reducing infections in fully vaccinated people and 80...
Read MoreMultidisciplinary care needed for COVID-19 long-haulers, study finds
Photo Cred: Olga Kononenko/Unsplash By Katherine Shagoury A new review published in the journal Nature Medicine offers an initial glimpse of the multi-organ effects of long-term novel coronavirus (COVID-19) and suggests a...
Read MoreInsomnia, disrupted sleep, burnout linked to higher risk of severe COVID-19
Photo Cred: Abbie Bernet/Unsplash By Katherine Shagoury Insomnia, disrupted sleep, and daily burnout are linked to a heightened risk of not only becoming infected with the novel coronavirus (COVID-19), but...
Read MoreStudy shows higher burden of COVID-19 compared to flu
Photo Cred: Kelly Sikkema/Unsplash By Katherine Shagoury A new study published in the Journal of General Internal Medicine compared the impact of the novel coronavirus (COVID-19) on patients and hospital...
Read MoreHigh vitamin D levels may protect against COVID-19
Photo Cred: Karolina Grabowska/Pexels By Katherine Shagoury In a new retrospective study at the University of Chicago Medicine published in JAMA Network Open of individuals tested for the novel coronavirus...
Read MoreColumbia physicians review “long-haul” COVD-19
Photo Cred: Gustavo Fring/Pexels By Katherine Shagoury The novel coronavirus (COVID-19) pandemic has taken the lives of millions of people around the world but has also left hundreds with lingering...
Read MoreAstraZeneca says vaccine effective, will seek FDA emergency use
Photo Cred: Karolina Grabowska/Pexels By Katherine Shagoury The AstraZeneca novel coronavirus (COVID-19) vaccine candidate, AZD1222, demonstrated 79 percent efficacy at preventing symptomatic COVID-19 and 100 percent efficacy at preventing severe...
Read More